DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME

Clinical trial NCT03321513 · COMPLETED

Trial details

NCT number: NCT03321513
Sponsor: Jaeb Center for Health Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2017-12-07
Primary completion: 2021-12-22
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.